Long-term follow-up of the STOPAGO study.
Journal: Blood
Published:
Abstract
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained a sustained response off treatment 4 years after treatment discontinuation.
Authors
Adrien Cottu, Stéphanie Guillet, Jean-françois Viallard, Etienne Rivière, Stéphane Cheze, Delphine Gobert, Antoine Neel, Julie Graveleau, Jean-pierre Marolleau, François Lefrere, Guillaume Moulis, Jean-christophe Lega, Aline Moignet Autrel, Ailsa Robbins, Etienne Crickx, Emmanuelle Boutin, Nicolas Noel, Marion Malphettes, Lionel Galicier, Sylvain Audia, Bernard Bonnotte, Olivier Lambotte, Olivier Fain, Mathieu Gerfaud Valentin, Louis Terriou, Nihal Martis, Anne-sophie Morin, Antoinette Perlat, Thomas Le Gallou, Frédérique Roy Peaud, Matthieu Puyade, Thibault Comont, Nicolas Limal, Laetitia Languille, Marc Michel, Bertrand Godeau, Matthieu Mahevas
Relevant Conditions